Literature DB >> 27631361

Sex Work as an Emerging Risk Factor for Human Immunodeficiency Virus Seroconversion Among People who Inject Drugs in the SurvUDI Network.

Karine Blouin1, Pascale Leclerc, Carole Morissette, Élise Roy, Caty Blanchette, Raymond Parent, Bouchra Serhir, Michel Alary.   

Abstract

BACKGROUND: Recent analyses have shown an emerging positive association between sex work and human immunodeficiency virus (HIV) incidence among people who inject drugs (PWIDs) in the SurvUDI network.
METHODS: Participants who had injected in the past 6 months were recruited across the Province of Quebec and in the city of Ottawa, mainly in harm reduction programs. They completed a questionnaire and provided gingival exudate for HIV antibody testing. The associations with HIV seroconversion were tested with a Cox proportional hazard model using time-dependent covariables including the main variable of interest, sexual activity (sex work; no sex work; sexually inactive). The final model included significant variables and confounders of the associations with sexual activity.
RESULTS: Seventy-two HIV seroconversions were observed during 5239.2 person-years (py) of follow-up (incidence rates: total = 1.4/100 py; 95% confidence interval [CI], 1.1-1.7; sex work = 2.5/100 py; 95% CI, 1.5-3.6; no sex work = 0.8/100 py; 95% CI, 0.5-1.2; sexually inactive = 1.8/100 py; 95% CI, 1.1-2.5). In the final multivariate model, HIV incidence was significantly associated with sexual activity (sex work: adjusted hazard ratio [AHR], 2.19; 95% CI, 1.13-4.25; sexually inactive: AHR, 1.62; 95% CI, 0.92-2.88), and injection with a needle/syringe used by someone else (AHR, 2.84; 95% CI, 1.73-4.66).
CONCLUSIONS: Sex work is independently associated with HIV incidence among PWIDs. At the other end of the spectrum of sexual activity, sexually inactive PWIDs have a higher HIV incidence rate, likely due to more profound dependence leading to increased vulnerabilities, which may include mental illness, poverty, and social exclusion. Further studies are needed to understand whether the association between sex work and HIV is related to sexual transmission or other vulnerability factors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27631361     DOI: 10.1097/OLQ.0000000000000504

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

1.  Factors Associated with Exchange Sex Among Cisgender Persons Who Inject Drugs: Women and MSM-23 U.S. Cities, 2018.

Authors:  Julie Rushmore; Kate Buchacz; Dita Broz; Christine B Agnew-Brune; Michelle L Johnson Jones; Susan Cha
Journal:  AIDS Behav       Date:  2022-06-25

Review 2.  Can Telemedicine Optimize the HCV Care Cascade in People Who Use Drugs? Features of an Innovative Decentralization Model and Comparison with Other Micro-Elimination Strategies.

Authors:  Riccardo Nevola; Valerio Rosato; Vincenza Conturso; Pasquale Perillo; Teresa Le Pera; Ferdinando Del Vecchio; Davide Mastrocinque; Annalisa Pappalardo; Simona Imbriani; Augusto Delle Femine; Alessia Piacevole; Ernesto Claar
Journal:  Biology (Basel)       Date:  2022-05-24

3.  HIV risk behaviours among women who inject drugs in coastal Kenya: findings from secondary analysis of qualitative data.

Authors:  Gitau Mburu; Mark Limmer; Paula Holland
Journal:  Harm Reduct J       Date:  2019-02-06

4.  Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Authors:  Chiedozie Arum; Hannah Fraser; Andreea Adelina Artenie; Sandra Bivegete; Adam Trickey; Michel Alary; Jacquie Astemborski; Jennifer Iversen; Aaron G Lim; Louis MacGregor; Meghan Morris; Jason J Ong; Lucy Platt; Rachel Sack-Davis; Daniela K van Santen; Sunil S Solomon; Vana Sypsa; Jorge Valencia; Wijnand Van Den Boom; Josephine G Walker; Zoe Ward; Jack Stone; Peter Vickerman
Journal:  Lancet Public Health       Date:  2021-03-26

Review 5.  Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.

Authors:  Louisa Degenhardt; Amy Peacock; Samantha Colledge; Janni Leung; Jason Grebely; Peter Vickerman; Jack Stone; Evan B Cunningham; Adam Trickey; Kostyantyn Dumchev; Michael Lynskey; Paul Griffiths; Richard P Mattick; Matthew Hickman; Sarah Larney
Journal:  Lancet Glob Health       Date:  2017-10-23       Impact factor: 26.763

6.  Impact of sex work on risk behaviours and their association with HIV positivity among people who inject drugs in Eastern Central Canada: cross-sectional results from an open cohort study.

Authors:  Laurence Campeau; Karine Blouin; Pascale Leclerc; Michel Alary; Carole Morissette; Caty Blanchette; Bouchra Serhir; Elise Roy
Journal:  BMJ Open       Date:  2018-01-31       Impact factor: 2.692

7.  Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.

Authors:  Young Jo; Tyler S Bartholomew; Susanne Doblecki-Lewis; Allan Rodriguez; David W Forrest; Jasmine Tomita-Barber; Juan Oves; Hansel E Tookes
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

8.  Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention.

Authors:  Suzan M Walters; Joey Platt; Amarachi Anakaraonye; Sarit A Golub; Chinazo O Cunningham; Brianna L Norton; Jae M Sevelius; Oni J Blackstock
Journal:  AIDS Behav       Date:  2021-06-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.